RecruitingNCT06906939
This study is looking at whether a digital support tool can help people with Knee Osteoarthritis or Depression. Participants take part in a digital support tool and complete follow-up assessments.
DepressionOtherFrom 50 Years to 95 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Depression
RecruitingNCT06775379
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
RecruitingNCT07076407
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Finland, Poland, Romania, Slovakia, United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
Not Yet RecruitingNCT07227103
This study is looking at whether ONE-D TMS can help people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionDrugFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
- Condition
- Depression
CompletedNCT05841030
This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
Active Not RecruitingNCT03642964
This study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Chase Therapeutics Corporation
- Condition
- Depression
TerminatedNCT05518149
This study is looking at whether Aticaprant can help people with major depression. Participants take part in Aticaprant and complete follow-up assessments.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07412756
This study is comparing Brenipatide with placebo for people with major depression. Participants receive Brenipatide or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
- Sponsor
- Eli Lilly and Company
- Condition
- Depression
RecruitingNCT05803551
This study is looking at care and outcomes for people with Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionDrugFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
RecruitingNCT06793397
This study is testing whether CYB003, compared with placebo, is safe and helpful as an add-on treatment for people with depression. Participants receive CYB003 or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 85 Years
- Countries
- Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
- Sponsor
- Cybin IRL Limited
- Condition
- Depression
RecruitingNCT07186309
This observational study is following people with Postpartum Depression or Pregnancy to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionDeviceOver 18 Years
- Countries
- United States
- Sponsor
- University of Virginia
- Condition
- Depression
RecruitingNCT06254612
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
- Condition
- Depression
Not Yet RecruitingNCT06710431
This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionDrugFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Afasci Inc
- Condition
- Depression
RecruitingNCT07276997
This study is comparing Icalcaprant with placebo for people with depression. Participants receive Icalcaprant or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Depression
RecruitingNCT06524830
This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Australia, Canada, United Kingdom, United States
- Sponsor
- atai Therapeutics, Inc.
- Condition
- Depression
RecruitingNCT07258485
This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07300969
This study is comparing DT-101 with placebo for people with depression. Participants receive DT-101 or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- Bulgaria, Czech Republic, Poland, United Kingdom, United States
- Sponsor
- Draig Therapeutics Ltd
- Condition
- Depression
RecruitingNCT07227454
This study is looking at care and outcomes for people with major depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionOtherFrom 12 Years to 17 Years
- Countries
- Brazil, Taiwan, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07065240
This study is looking at whether SPT-300 can help people with depression or depression With Anxious Distress. Participants take part in SPT-300 and complete follow-up assessments.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Czech Republic, Germany, Poland, Slovakia, United States
- Sponsor
- Seaport Therapeutics
- Condition
- Depression
RecruitingNCT06223880
This study is looking at whether AXS-05 can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Axsome Therapeutics, Inc.
- Condition
- Depression
RecruitingNCT07196501
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionOtherOver 18 Years
- Countries
- Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, United States
- Sponsor
- Neurocrine Biosciences
- Condition
- Depression
RecruitingNCT06570369
This study is comparing SP-624 with placebo for people with depression or Healthy. Participants receive SP-624 or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
- Condition
- Depression
RecruitingNCT06785012
This study is comparing JNJ-89495120 with placebo for people with major depression. Participants receive JNJ-89495120 or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07047820
This observational study is following people with Depression, Postpartum to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionDrugOver 18 Years
- Countries
- United States
- Sponsor
- Biogen
- Condition
- Depression
Active Not RecruitingNCT05931432
This study is looking at whether a digital support tool can help people with Depression, Anxiety, Satisfaction, or Well-being. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Pennsylvania
- Condition
- Depression